PT
Autoridade da Concorrência

Case details

Print
Merger control
Case reference
CCENT/2007/68 - RECORDATI/OE
Acquired
Orphan Europe Holding, S.A.
Description
the holding company of a pharmaceutical group that specialises in research into and the development, production and distribution of drugs for the treatment of patients suffering from rare diseases (orphan medical products); the group sells these products worldwide through its head office in France.
Acquiring
Recordati - Industria Chimica e Farmacêutica, S.p.A.
Description
an Italian-registered company that, as the holding company of the pharmaceutical group RECORDATI, is engaged, through its subsidiaries, in pharmaceutical product research, development, production and marketing in various countries throughout the world. In Portugal, RECORDATI operates through its subsidiary Jaba Farmacêutica SA.
Sector
  • Supply and Food Industry
Activity (NACE)
  • G46 - Wholesale trade (include commission trade), except of motor vehicles and motorcycles
Applicable legislation
Art. 9(1)(a) (Law 18)
Notification thresholds
Market share
Type of merger
Conglomerate
Cooperation with sector regulators
Status
Closed
Type of Investigation
Phase 1
AdC’s decision
Non-opposition
Case description
Notified on 11 October 2007, this mereger consists of the acquisition, by Recordati - Industria Chimica e Farmacêutica SpA (hereafter "RECORDATI"), of exclusive control of OE Holding SA (hereafter "OE"), through the acquisition of its total registered capital.
Timeline
2007-11-12
2007-10-17
Publication of the announcement
Click here to see your activities